Flynotes, a Manchester-based digital healthcare consent platform, has secured funding from NPIF-Maven Equity Finance. The platform provides a simple and effective way for doctors and dentists to gain valid and informed consent from patients before delivering medical and dental treatments. The interface removes the inefficiencies of paper forms, while delivering a complete and compliant audit trail.
The business’ niche and highly scalable product is targeting a £1.2 billion global market, and has agreed to a commercial partnership with Henry Schein. Henry Schein is a global distributor of medical and dental goods and operates in thirty-two countries supplying over 80,000 practices.
Maven Capital Partners, part of the Northern Powerhouse Investment Fund, and Catapult Ventures, which handles GM&C Life Sciences Fund manage NPIF-Maven Equity Finance. The investment will enable Flynotes to invest in product development and expand its sales team to support international growth.
Maven Investment Manager, Gavin Bell, said that “Flynotes impressed [Maven] with their ambition and ability to innovate in a sector that needs low touch digital solutions now more than ever. We’re delighted to be partnering with the team and Catapult Ventures to support the next stage of development.”